Bicycle Therapeutics plc (BCYC) Financials
BCYC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 606.6 million | 96.3 million |
| March 31, 2026 | 652.4 million | 98.1 million |
| Dec. 31, 2025 | 717.6 million | 107.6 million |
| Sept. 30, 2025 | 764.0 million | 145.5 million |
BCYC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -49.9 million | 6.4 million |
| March 31, 2026 | -66.6 million | 6.9 million |
| Dec. 31, 2025 | -17.2 million | -27.8 million |
| Sept. 30, 2025 | -71.8 million | 8.8 million |
BCYC Net Income
No data available :(
BCYC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 510.1 million | - | 13.7 million |
| March 31, 2026 | 559.5 million | - | 15.3 million |
| Dec. 31, 2025 | 628.1 million | - | 16.9 million |
| Sept. 30, 2025 | 648.3 million | - | 5.7 million |
BCYC Shares Outstanding
BCYC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 265000 | 41.2 million | 14.0 million | - |
| March 31, 2026 | 713000 | 48.9 million | 17.6 million | - |
| Dec. 31, 2025 | 1.8 million | 51.8 million | 20.8 million | 199000 |
| Sept. 30, 2025 | 674000 | 58.4 million | 19.0 million | - |
BCYC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 629000 | - |
| March 31, 2026 | 887000 | - |
| Dec. 31, 2025 | 48.0 million | 35.1 million |
| Sept. 30, 2025 | 11.7 million | - |
BCYC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BCYC
Price: $3.90
52 week price:
Earnings Per Share: -2.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 365200
Market Capitalization: 277.9 million